Cardiac CryoAblation System
You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
Cardiac CryoAblation System
The CryoConsole is the device that powers the Arctic Front Advance™ Cardiac CryoAblation Catheter and the Freezor™ MAX Cardiac CryoAblation Catheter. The console houses the electrical and mechanical components and software needed to perform cryoablation procedures. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.
The CryoConsole encompasses the electrical and mechanical components and proprietary software for controlling a cryotherapy procedure with the Arctic Front Advance and Freezor MAX catheters. It stores and controls the delivery of the liquid refrigerant (N2O) through the coaxial umbilical to the catheter, recovers the refrigerant vapor from the catheter under constant vacuum, and disposes of the refrigerant through the hospital scavenging system. Multiple features are built into the catheters and the CryoConsole to promote safety.
The CryoConsole features ergonomic design, a height-adjustable monitor, and touch-screen control for a straightforward procedure.
Patient data and therapy variables are managed by a simple touch-screen interface. The screen also displays numerical and graphical data to help physicians and staff assess the status of the system, catheter-tissue contact, ablation time, and catheter temperatures. The CryoConsole can transmit information about the procedure to other EP recording systems for display purposes.
The CryoConsole safely manages the delivery, recovery, and disposal of N2O during cryoablation procedures. Its components and software operate the Arctic Front Advance and Freezor MAX catheters, and provide continuous monitoring ensuring system safety.
During a cardiac ablation procedure, pressurized liquid nitrous oxide (N2O) is delivered from a tank in the CryoConsole. The liquid refrigerant travels in an ultra-fine tube through the coaxial umbilical and the shaft of the cryoablation catheter to the tip of the catheter.
The liquid refrigerant vaporizes as it is sprayed into the tip. As it vaporizes, it absorbs heat from the surrounding tissue, thereby cooling and freezing the target tissue. The warmed refrigerant is vacuumed back to the CryoConsole through a large lumen within the shaft of the catheter and coaxial umbilical. The CryoConsole discharges the vapor into the hospital scavenging system.
The CryoConsole is compatible with the Arctic Front Advance™ and Freezor MAX catheters.
Height (max): 157 cm
Height (min): 126 cm
Depth: 59 cm
Width: 55 cm
Weight: 131 kg (without nitrous oxide tank)
Power input parameters: 110/120/230V
Operational parameters: 15-30°C; maximum of 75% humidity
Refrigerant: Liquified nitrous oxide (N2O); 99.5% purity with humidity level < 50 ppm
In addition to the CryoConsole and the cryoablation catheters, the Cardiac CryoAblation System consists of sterile, single-use cables, as well as nonsterile accessories. The coaxial umbilical provides the refrigerant transport to the catheter and vapor recovery to the CryoConsole. The electrical umbilical provides the electrical connection between the catheter and the CryoConsole. The Auto Connection Box provides an electrical interface to the catheter. The ECG cable provides an interface between the catheter and a standard ECG monitor (via 2 mm touch-proof connectors). The scavenging hose is used to connect the CryoConsole to the hospital scavenging system.
For any questions, please contact:
AF Solutions Technical Support
Toll-free: 1 (877) 464-2796
IMPORTANT INFORMATION ON INDICATIONS, SAFETY AND WARNINGS
For listing of Indications, Contraindications, Warnings, Precautions, and Potential Adverse Events, please refer to the Instructions For Use .